Market Closed -
Other stock markets
|
After market 05:29:42 am | |||
40.49 USD | -1.82% | 40.52 | +0.07% |
28/05 | Prothena to Receive $80 Million From Bristol-Myers Squibb For PRX019 Global License | MT |
27/05 | Bristol Myers: will present data on schizophrenia | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.09% | 83.6B | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Morgan Stanley Cuts Price Target on Bristol-Myers Squibb to $50 From $56, Says Lower Medium-Term Guidance Raises Questions on 2030 Targets, Keeps Underweight Rating